Mehboob Hoque

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 18

Top Topics

Molecular Docking

Angiotensin Converting Enzyme

Top Venues

Functional & integrative genomics

Journal of cellular biochemistry

Molecules (Basel, Switzerland)

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Ashif Ahamed, Arijit Samanta, Syed Sahajada Mahafujul Alam, Showkat Ahmad Mir, Zarnain Jamil, Safdar Ali, Mehboob Hoque
Nonsynonymous mutations in VEGF receptor binding domain alter the efficacy of bevacizumab treatment. Journal of cellular biochemistry 125 (2) (2024)
Ashif Ahamed, Arijit Samanta, Syed Sahajada Mahafujul Alam, Showkat Ahmad Mir, Zarnain Jamil, Safdar Ali, Mehboob Hoque
Nonsynonymous mutations in VEGF receptor binding domain alter the efficacy of bevacizumab treatment. Journal of cellular biochemistry 125 (2) (2024)
Ashif Ahamed, Arijit Samanta, Syed Sahajada Mahafujul Alam, Showkat Ahmad Mir, Zarnain Jamil, Safdar Ali, Mehboob Hoque
Nonsynonymous mutations in VEGF receptor binding domain alter the efficacy of bevacizumab treatment. Journal of cellular biochemistry (2024)
Ashif Ahamed, Arijit Samanta, Syed Sahajada Mahafujul Alam, Showkat Ahmad Mir, Zarnain Jamil, Safdar Ali, Mehboob Hoque
Nonsynonymous mutations in VEGF receptor binding domain alter the efficacy of bevacizumab treatment. Journal of cellular biochemistry 125 (2) (2024)
Arijit Samanta, Syed Sahajada Mahafujul Alam, Safdar Ali, Mehboob Hoque
Evaluating the transmission feasibility of SARS-CoV-2 Omicron (B.1.1.529) variant to 143 mammalian hosts: insights from S protein RBD and host ACE2 interaction studies. Functional & integrative genomics 23 (1) (2023)
Arijit Samanta, Syed Sahajada Mahafujul Alam, Safdar Ali, Mehboob Hoque
Evaluating the transmission feasibility of SARS-CoV-2 Omicron (B.1.1.529) variant to 143 mammalian hosts: insights from S protein RBD and host ACE2 interaction studies. Functional & integrative genomics 23 (1) (2023)
Arijit Samanta, Syed Sahajada Mahafujul Alam, Safdar Ali, Mehboob Hoque
Evaluating the transmission feasibility of SARS-CoV-2 Omicron (B.1.1.529) variant to 143 mammalian hosts: insights from S protein RBD and host ACE2 interaction studies. Functional & integrative genomics 23 (1) (2023)
Arijit Samanta, Syed Sahajada Mahafujul Alam, Safdar Ali, Mehboob Hoque
Evaluating the transmission feasibility of SARS-CoV-2 Omicron (B.1.1.529) variant to 143 mammalian hosts: insights from S protein RBD and host ACE2 interaction studies. Functional & integrative genomics 23 (1) (2023)
Syed Sahajada Mahafujul Alam, Arijit Samanta, Faizan Uddin, Safdar Ali, Mehboob Hoque
Tanshinone IIA targeting cell signaling pathways: a plausible paradigm for cancer therapy. Pharmacological reports : PR (2023)
Iftikhar Ahmad, Mehboob Hoque, Syed Sahajada Mahafujul Alam, Torki Al Zughaibi, Shams Tabrez
Curcumin and Plumbagin Synergistically Target the PI3K/Akt/mTOR Pathway: A Prospective Role in Cancer Treatment. International journal of molecular sciences 24 (7) (2023)
Arijit Samanta, Syed Sahajada Mahafujul Alam, Safdar Ali, Mehboob Hoque
Evaluating the transmission feasibility of SARS-CoV-2 Omicron (B.1.1.529) variant to 143 mammalian hosts: insights from S protein RBD and host ACE2 interaction studies. Functional & integrative genomics 23 (1) (2023)
Shams Tabrez, Torki Al Zughaibi, Mehboob Hoque, Mohd Suhail, Mohammad Imran Khan, Azhar U Khan
Correction: Tabrez et al. Targeting Glutaminase by Natural Compounds: Structure-Based Virtual Screening and Molecular Dynamics Simulation Approach to Suppress Cancer Progression. Molecules 2022, 27 , 5042. Molecules (Basel, Switzerland) 28 (1) (2022)
Adel M Abuzenadah, Fatin Al-Sayes, Syed Sahajada Mahafujul Alam, Mehboob Hoque, Sajjad Karim, Ibtessam Ramzi Hussein, Shams Tabrez
Elucidating Antiangiogenic Potential of Rauwolfia serpentina : VEGFR-2 Targeting-Based Molecular Docking Study. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Adel M Abuzenadah, Fatin Al-Sayes, Syed Sahajada Mahafujul Alam, Mehboob Hoque, Sajjad Karim, Ibtessam Ramzi Hussein, Shams Tabrez
Identification of Potential Poly (ADP-Ribose) Polymerase-1 Inhibitors Derived from Rauwolfia serpentina : Possible Implication in Cancer Therapy. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Munazza Tamkeen Fatima, Zeyaul Islam, Ejaj Ahmad, Mehboob Hoque, Marriam Yamin
Plasma Bead Entrapped Liposomes as a Potential Drug Delivery System to Combat Fungal Infections. Molecules (Basel, Switzerland) 27 (3) (2022)
Shams Tabrez, Torki Al Zughaibi, Mehboob Hoque, Mohd Suhail, Mohammad Imran Khan, Azhar U Khan
Correction: Tabrez et al. Targeting Glutaminase by Natural Compounds: Structure-Based Virtual Screening and Molecular Dynamics Simulation Approach to Suppress Cancer Progression. Molecules 2022, 27 , 5042. Molecules (Basel, Switzerland) 28 (1) (2022)
Shams Tabrez, Torki Al Zughaibi, Mehboob Hoque, Mohd Suhail, Mohammad Imran Khan, Azhar U Khan
Correction: Tabrez et al. Targeting Glutaminase by Natural Compounds: Structure-Based Virtual Screening and Molecular Dynamics Simulation Approach to Suppress Cancer Progression. Molecules 2022, 27 , 5042. Molecules (Basel, Switzerland) 28 (1) (2022)
Zarnain Jamil, Arif Uddin, Syed Sahajada Mahafujul Alam, Arijit Samanta, Nojood Altwaijry, Mohd Ahmar Rauf, Safdar Ali, Mohd Shahnawaz Khan, Muhammad Nadeem Asghar, Mehboob Hoque
Analysis of the Compositional Features and Codon Usage Pattern of Genes Involved in Human Autophagy. Cells 11 (20) (2022)